Dementia drugs market is estimated to grow at a significant CAGR during the forecast period. In recent years there has been a lot of progress in terms of developing drugs for dementia utilizing various approaches. For instance, the new approaches include moving on from a target-centric approach to innovative molecular probes that includes the study of changing the level of the proteins and many more. The innovative and new approach adopted in the drug development of dementia is anticipated to drive the global dementia drug market considerably.
Additionally, the engagement of key market players and renowned institutes such as UCLA and Oxford in the drug development will also impact the global dementia drug market size. In addition, neurodegenerative disorders such as dementia and its associated conditions including Alzheimer’s disease and Parkinson’s disease are characterized by the accumulation and aggregation of misfolded proteins. Hence, a great emphasis on the studies related to how the cells respond to the misfolded proteins, and its process called unfolded protein response is being given for the drug development. For instance, the research on misfold protein is also taking place at the University of Cambridge which is anticipated to drive the dementia drug industry significantly during the forecast period.
However, apart from the new approaches, the main target for the dementia drug development has been on treatments that focus on amyloid accumulation. Hence, the availability of BACE inhibitors and various antibodies targeting beta-amyloid in the brain is increasing the potential of detention drug market share. Moreover, the roles of various parts of the brain such as astrocytes and microglia and neuroinflammation have also been discovered in some recent studies. The better understanding of astrocytes and microglia and neuroinflammation in dementia will also present new opportunities for the dementia drug industry growth. In addition to this, the treatment approaches that combine more than one dementia drugs will also drive the market during the forecast period.
To Request a Sample of our Report on Dementia Drugs Market: https://www.omrglobal.com/request-sample/dementia-drugs-market
Dementia Drugs Market- Segmentation
By Type of Dementia
- Lewy Body Dementia
- Parkinson’s Disease Dementia
- Alzheimer’s Disease
- Others
By Type of Drugs
- Cholinesterase Inhibitors
- MAO Inhibitors
- Glutamate Inhibitors
- Others
A full Report of Dementia Drugs Market is Available @ https://www.omrglobal.com/industry-reports/dementia-drugs-market
Dementia Drugs Market- Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbvie Inc.
- ACADIA Pharmaceuticals Inc.
- Apotex Corp.
- Aurobindo Pharma Ltd.
- Biogen Inc.
- Boehringer Ingelheim GmbH
- Eisai Co., Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Impax Laboratories, Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Vertical Pharmaceuticals, LLC
- Zydus Pharmaceuticals, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
